Abstract
Actinomycin D (0.6 mg/kg, i.p.) enhances the radiation response of mouse lung. The degree of enhancement varies inversely with the interval between radiation and drug treatments. The kinetics of the loss of interaction of the drug with radiation damage is similar to that observed for 'slow repair' of radiation injury to the lung.
Original language | English (US) |
---|---|
Pages (from-to) | 511-512 |
Number of pages | 2 |
Journal | International Journal of Radiation Oncology, Biology, Physics |
Volume | 8 |
Issue number | 3-4 |
DOIs | |
State | Published - 1982 |
Externally published | Yes |
Keywords
- Actinomycin D
- Lung
- Radiation injury
- Type 2 pneumocytes
ASJC Scopus subject areas
- Radiation
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research